supp.fit

Bergamot: study protocols

18 study groups say how much Bergamot participants took a day. These are the doses the studies gave. They are not a recommendation.

Bergamot: what the research found →

Dose per serving from research

17 study groups in 8 studies say how much Bergamot participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 41% of 17 study groups.

Daily doseStudy groups
100 mg to 250 mg
4
250 mg to 500 mg
4
500 mg to 1 g
7
1 g to 2.5 g
2

Commonly used together

11 of 18 study groups took Bergamot with something else, but nothing that 3 or more different studies gave.

18 study groups

Study
Bergamot phytosome improved visceral fat and plasma lipid profiles in overweight and obese class I subject with mild hypercholesterolemia: A randomized placebo controlled trial
2021 · Active intervention: Bergamot Phytosome · Adults aged 18–60 with overweight or class I obesity and newly diagnosed mild hypercholesterolemia
1 g12 weeks33
Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols
2019 · BPE-C high · Males and females aged 40–80 with metabolic syndrome, obesity (BMI >26), elevated triglycerides and total cholesterol, and moderate hyperglycemia
1.3 g90 days18
Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols
2019 · BPE-C low · Males and females aged 40–80 with metabolic syndrome, obesity (BMI >26), elevated triglycerides and total cholesterol, and moderate hyperglycemia
650 mg90 days17
Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia
2013 · BPF alone · Patients with mixed hyperlipidemia and elevated serum LDL-C and triglycerides
1 g30 days15
Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia
2013 · BPF plus rosuvastatin 10 mg/day · Patients with mixed hyperlipidemia and elevated serum LDL-C and triglycerides
1 g30 days15
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 2 · male athletes (cyclists)
500 mg90 days10
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 3 · male athletes (cyclists)
1 g90 days10
Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia
2021 · Supplement group · Adults aged 18–65 years, both sexes, with mild hypercholesterolemia and a previous poor response to bergamot; no history of cardiovascular disease
1.2 g60 days30
Antioxidant-Enriched Diet on Oxidative Stress and Inflammation Gene Expression: A Randomized Controlled Trial
2023 · MedDiet + MAB juice · Healthy adults aged 18–65 years with BMI 19–29.90 kg/m²
250 mL2 weeks24
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 6 · male athletes (cyclists)
500 mg90 days10
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 7 · male athletes (cyclists)
500 mg90 days10
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 8 · male athletes (cyclists)
1 g90 days10
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study
2025 · Group 9 · male athletes (cyclists)
1 g90 days10
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease
2022 · BPF + CyC group · Adults aged 30–75 of all genders with NAFLD
150 mg12 weeks—
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
2022 · Nutraceutical (Livogen Plus®) · Adults aged 30–75 with hepatic steatosis (NAFLD), without diabetes
400 mg12 weeks70
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects
2019 · low-dose active treatment · overweight adults with dyslipidemia
120 mg8 weeks—
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects
2019 · high-dose active treatment · overweight adults with dyslipidemia
120 mg8 weeks—
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects
2019 · combination of active treatment and placebo (one pill per treatment) · overweight adults with dyslipidemia
120 mg8 weeks—